Market interprets latest change in CEO as negative. Perhaps indicative of a longer wait before licensing agreement is signed. How low can this go?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025